日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1

来自多发性骨髓瘤患者的骨髓来源细胞外囊泡通过 HLA-G、PD-1 和 PD-L1 促进适应性免疫功能障碍

Debora Soncini ,Danilo Marimpietri ,Francesco Ladisa ,Francesco Lai ,Irma Airoldi ,Roberto Gramignoli ,Michele Cea ,Fabio Morandi

JNJ-78306358, a first-in-class bispecific T cell engaging antibody targeting CD3 and HLA-G

JNJ-78306358 是一种首创的双特异性 T 细胞接合抗体,靶向 CD3 和 HLA-G。

Nataša Obermajer ,Adam Zwolak ,Kelly van de Ven ,Shana Versmissen ,Krista Menard ,Katharine Rogers ,Ted Petley ,Dan Weinstock ,Jason Aligo ,Jaymala Patel ,Ken Tian ,Lorraine Angelillo ,Fang Yi ,Stephen Jarantow ,Keith Schutsky ,Yoshitomo Hamuro ,Diana Alvarez Arias ,Kristel Buyens ,Tsun-Wen Sheena Yao ,Vince Torti ,Aleksandra Brajic ,Brian Geist ,Marjolein van Heerden ,Gerald Chu ,Bie Verbist ,Maté Ongenaert ,Julien Häsler ,Kathryn Packman ,Jacintha Shenton ,Laurie Lenox ,Jacalyn Clawson ,Regina J Brown ,Josh Lauring ,James G Greger ,Dirk Brehmer ,Sanjaya Singh ,Matthew V Lorenzi ,Sylvie Laquerre

LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis

LILRB1-HLA-G轴定义了结核病中驱动自然杀伤细胞耗竭的检查点

Jing Wang # ,Qiyao Chai # ,Zehui Lei # ,Yiru Wang # ,Jiehua He # ,Pupu Ge ,Zhe Lu ,Lihua Qiang ,Dongdong Zhao ,Shanshan Yu ,Changgen Qiu ,Yanzhao Zhong ,Bing-Xi Li ,Lingqiang Zhang ,Yu Pang ,George Fu Gao ,Cui Hua Liu

HLA-G neo-expression modifies genetic programs governing tumor cell lines

HLA-G新表达改变肿瘤细胞系的遗传程序

Diana Tronik-Le Roux ,Marina Daouya ,Isabelle Poras ,François Desgrandchamps ,Edgardo D Carosella

IDO-1 impairs antitumor immunity of natural killer cells in triple-negative breast cancer via up-regulation of HLA-G

IDO-1通过上调HLA-G削弱三阴性乳腺癌中自然杀伤细胞的抗肿瘤免疫力。

Rui Jing ,Shukun Bai ,Peipei Zhang ,Hao Ren ,Lintao Jia ,Weimiao Li ,Guoxu Zheng

CAR-T cells targeting HLA-G as potent therapeutic strategy for EGFR-mutated and overexpressed oral cancer

靶向HLA-G的CAR-T细胞是治疗EGFR突变和过表达口腔癌的有效策略

Yu-Chuan Lin ,Chun-Hung Hua ,Hsin-Man Lu ,Shi-Wei Huang ,Yeh Chen ,Ming-Hsui Tsai ,Fang-Yu Lin ,Peter Canoll ,Shao-Chih Chiu ,Wei-Hua Huang ,Der-Yang Cho ,Chia-Ing Jan

Utilizing primary HLA-G+ extravillous trophoblasts and HLA-G+ EVT-like cell lines to study maternal-fetal interactions

利用原代HLA-G+绒毛外滋养层细胞和HLA-G+ EVT样细胞系研究母胎相互作用

Ira Hamilton ,Nadia M Ikumi ,Sarika Kshirsagar ,Wendy A Goodman ,Tamara Tilburgs

Induction of pulmonary HLA-G expression by SARS-CoV-2 infection

SARS-CoV-2感染诱导肺部HLA-G表达

Barbara Seliger ,Simon Jasinski-Bergner ,Chiara Massa ,Anja Mueller ,Katharina Biehl ,Bo Yang ,Michael Bachmann ,Danny Jonigk ,Philip Eichhorn ,Arndt Hartmann ,Claudia Wickenhauser ,Marcus Bauer

Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab

HLA-G 与 NK 细胞受体 KIR2DL4 之间的相互作用导致 HER2 阳性乳腺癌对曲妥珠单抗产生耐药性

Guoxu Zheng # ,Zhangyan Guo # ,Weimiao Li # ,Wenjin Xi ,Baile Zuo ,Rui Zhang ,Weihong Wen ,An-Gang Yang ,Lintao Jia

Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC

HLA-G-ILT2检查点对iNKT细胞的抑制以及表达HLA-G的耐受性树突状细胞对iNKT细胞的刺激作用较弱

Ching-Lien Wu ,Julien Caumartin ,Giada Amodio ,François Anna ,Maria Loustau ,Silvia Gregori ,Pierre Langlade-Demoyen ,Joel LeMaoult